Basics Dyne Therapeutics, Inc. IPO Date: September 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.9B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.25% Avg Daily Range (30 D): $0.75 | 3.64% Avg Daily Range (90 D): $0.48 | 2.99% Institutional Daily Volume Avg Daily Volume: .79M Avg Daily Volume (30 D): 2.6M Avg Daily Volume (90 D): 2.35M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 86 Institutional Trades Total Inst.Trades: 2,121 Avg Inst. Trade: $2.49M Avg Inst. Trade (30 D): $1.74M Avg Inst. Trade (90 D): $1.89M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.1M Avg Closing Trade (30 D): $4.93M Avg Closing Trade (90 D): $4.25M Avg Closing Volume: 218.24K     News Oct 27, 2025 @ 10:17 PM Why Dyne Therapeutics Stock Crushed the Market on ... Source: Eric Volkman Sep 29, 2025 @ 12:35 PM Dyne Therapeutics Receives Orphan Drug Designation... Source: Globe Newswire Aug 28, 2025 @ 5:00 PM Antisense Oligonucleotide Therapeutics Clinical Tr... Source: Delveinsight Aug 17, 2025 @ 4:42 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp Aug 9, 2025 @ 4:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.62 $-.76 $-.97 Diluted EPS $-3.62 $-.76 $-.97 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -423.8M $ -108.04M $ -110.86M Operating Income / Loss $ -449.16M $ -113.89M $ -115.79M Cost of Revenue $ $ $ Net Cash Flow $ 41.53M $ 88.58M $ 12.85M PE Ratio